Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCNAB1 antisense RNA 1 (KCNAB1-AS1) is a long non-coding RNA (lncRNA) gene distinct from the protein-coding KCNAB1 gene. It is classified as an antisense RNA as it is transcribed from the DNA strand opposite the KCNAB1 gene, potentially allowing it to regulate the expression of KCNAB1 through various mechanisms typical of antisense RNAs, such as RNA interference or transcriptional interference[5][6][8][12]. Its precise biological function, disease involvement, and therapeutic relevance remain undetermined due to the lack of functional studies and disease associations in current databases and literature[5][6][8][12]. KCNAB1-AS1 is not considered a typical therapeutic target such as a receptor, enzyme, or transporter, nor are there known drugs that interact with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KCNAB1 antisense RNA 1 (KCNAB1-AS1).